New Delhi: Pharmaceutical Firm FDC Ltd said on Monday that it has launched a favipiravir oral suspension to treat covid-19 cases that are light to medium.
Favenza oral suspension is only this recipe available at all retail medical outlets and hospital pharmacies throughout India, FDC said in a statement.
The comfortable loading dose of oral suspensions helps reduce the frequency of doses, he added.
“With positive cases it increases again, now is the time to provide health care soldiers in our country with proper options in a sustainable battle against this disease.
To fight Covid-19, we believe in offering the best efficacy to us patients and therefore we have had Focusing our efforts in making the Covid-19 Treatment Process Free, “FDC Business Development & Commercial Advantages of General Manager Mayank Tikkha.
FDC Launches Favipiravir Oral Suspension to Treat Covid-19 in India
